GAM Holding’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,062
Closed -$278K 239
2022
Q2
$278K Hold
7,062
0.02% 234
2022
Q1
$494K Sell
7,062
-1
-0% -$73 0.02% 224
2021
Q4
$550K Hold
7,063
0.02% 235
2021
Q3
$674K Buy
7,063
+1
+0% +$106 0.03% 217
2021
Q2
$878K Sell
7,062
-1
-0% -$119 0.04% 235
2021
Q1
$931K Buy
+7,063
New +$967K 0.04% 242
2020
Q4
Sell
-48,505
Closed -$4.95M 291
2020
Q3
$4.95M Buy
48,505
+10
+0% +$864 0.3% 102
2020
Q2
$4.22M Sell
48,495
-11
-0% -$879 0.26% 113
2020
Q1
$2.81M Buy
48,506
+9,705
+25% +$788K 0.19% 142
2019
Q4
$3.59M Buy
38,801
+6,280
+19% +$552K 0.17% 155
2019
Q3
$2.94M Buy
32,521
+826
+3% +$94.1K 0.13% 180
2019
Q2
$3.74M Hold
31,695
0.15% 158
2019
Q1
$2.75M Buy
+31,695
New +$2.7M 0.12% 201

Other funds holding EXAS

GAM Holding's EXAS Position: Q3 2022 in Review

GAM Holding sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 7,062 shares — an estimated $278K sold.

GAM Holding first reported a position in EXAS in Q1 2019 and held it in 13 quarters. The position peaked at $4.95M in Q3 2020. 479 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

  • GAM Holding reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
  • GAM Holding sold 7,062 Exact Sciences shares in Q3 2022, an estimated $278K.
  • GAM Holding first reported a position in Exact Sciences in Q1 2019 and held it in 13 quarters.
  • GAM Holding's Exact Sciences position peaked at $4.95M in Q3 2020.
  • 479 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on GAM Holding's 13F filing for Q3 2022, filed 19 Oct 2022.